TRCT
VERA icon

Tower Research Capital (TRC)’s Vera Therapeutics VERA Stock Holding History

Tower Research Capital (TRC)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Buy
3,880
+3,343
+623% +$144K ﹤0.01% 1815
2025
Q4 		$27.2K Sell
537
-2,639
-83% -$93.7K ﹤0.01% 2871
2025
Q3 		$92.3K Sell
3,176
-1,010
-24% -$23.4K ﹤0.01% 2056
2025
Q2 		$98.6K Buy
4,186
+2,757
+193% +$62K ﹤0.01% 2386
2025
Q1 		$34.3K Sell
1,429
-9,046
-86% -$291K ﹤0.01% 2513
2024
Q4 		$443K Buy
10,475
+10,235
+4,265% +$453K 0.01% 1153
2024
Q3 		$10.6K Sell
240
-5,667
-96% -$215K ﹤0.01% 3738
2024
Q2 		$214K Buy
5,907
+5,443
+1,173% +$216K ﹤0.01% 2021
2024
Q1 		$20K Sell
464
-7,831
-94% -$279K ﹤0.01% 2999
2023
Q4 		$128K Buy
8,295
+5,956
+255% +$75.6K ﹤0.01% 2445
2023
Q3 		$32.1K Buy
2,339
+411
+21% +$7.05K ﹤0.01% 2968
2023
Q2 		$30.9K Sell
1,928
-2,906
-60% -$26.2K ﹤0.01% 2999
2023
Q1 		$38K Buy
4,834
+4,303
+810% +$33.2K ﹤0.01% 2764
2022
Q4 		$10K Sell
531
-1,004
-65% -$18.2K ﹤0.01% 4089
2022
Q3 		$33K Buy
1,535
+105
+7% +$1.97K ﹤0.01% 3532
2022
Q2 		$19K Buy
1,430
+1,203
+530% +$21K ﹤0.01% 3863
2022
Q1 		$5K Sell
227
-311
-58% -$6.69K ﹤0.01% 5111
2021
Q4 		$14K Sell
538
-67
-11% -$1.48K ﹤0.01% 4115
2021
Q3 		$10K Buy
+605
New +$10.8K ﹤0.01% 4343

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tower Research Capital (TRC)'s VERA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Vera Therapeutics (VERA) stake by 623% in Q1 2026, buying an estimated $144K and bringing the position to 3,880 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

Tower Research Capital (TRC) first reported a position in VERA in Q3 2021 and has held it in 19 quarters since. The position peaked at $443K in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Tower Research Capital (TRC) held 3,880 shares of Vera Therapeutics worth $156K as of Q1 2026.
  • Tower Research Capital (TRC) bought 3,343 Vera Therapeutics shares in Q1 2026, an estimated $144K.
  • Vera Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1815 holding.
  • Tower Research Capital (TRC) first reported a position in Vera Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Vera Therapeutics position peaked at $443K in Q4 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.